Mesoblast Limited (MESO)
NASDAQ: MESO · Real-Time Price · USD
15.43
-0.07 (-0.45%)
At close: Sep 11, 2026, 4:00 PM EDT
15.48
+0.05 (0.32%)
After-hours: Sep 11, 2026, 7:30 PM EDT
Mesoblast Market Cap
Mesoblast has a market cap or net worth of $2 billion as of September 11, 2026. Its market cap has increased by 0.54% in one year.
Market Cap
2.00B
Enterprise Value
2.03B
1-Year Change
0.54%
Ranking
Category
Stock Price
$15.43
ChartMarket Cap Chart
Since November 13, 2015, Mesoblast's market cap has increased from $593.20M to $2.00B, an increase of 237.55%. That is a compound annual growth rate of 11.88%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 2.01B | -13.06% |
| Dec 31, 2025 | 2.31B | 2.14% |
| Dec 31, 2024 | 2.26B | 1,162.26% |
| Dec 29, 2023 | 179.10M | -58.22% |
| Dec 30, 2022 | 428.70M | -31.15% |
| Dec 31, 2021 | 622.70M | -37.40% |
| Dec 31, 2020 | 994.70M | 35.19% |
| Dec 31, 2019 | 735.80M | 84.92% |
| Dec 31, 2018 | 397.90M | -27.59% |
| Dec 29, 2017 | 549.50M | 34.55% |
| Dec 30, 2016 | 408.40M | -12.21% |
| Dec 31, 2015 | 465.20M | -21.58% |
| Nov 13, 2015 | 593.20M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ADMA Biologics | 2.10B |
| Rapport Therapeutics | 2.09B |
| UroGen Pharma | 2.06B |
| Kodiak Sciences | 2.06B |
| Zenas BioPharma | 2.03B |
| Agios Pharmaceuticals | 2.01B |
| Generate Biomedicines | 1.98B |
| Vericel | 1.94B |